Reinvention: The Future of Cancer & Biomedical Innovation — and Careers

Join us for an inspiring fireside evening with Prof Toh Han Chong, the Deputy CEO (Strategic Partnerships) of the National Cancer Centre Singapore and Professor at Duke-NUS. With an impressive background as a clinician-scientist and immunotherapy pioneer, he has been a key player in the global VANCE Phase III trial — the largest T-cell therapy trial in solid tumors — and co-founded NeoTILa Biosciences.

This unique opportunity allows you to hear candid insights from Prof Chong as he discusses:

• Identifying Opportunities: How do you determine if an idea should become a company?
• Exciting vs. Investable Science: What differentiates thrilling research from scalable ventures?
• Building Ecosystems: How a small nation successfully created a leading biomedical landscape and the current opportunities available in Asia.
• Essential Learning: What should today’s grad students focus on that traditional training often overlooks?

✨ This event is perfect for:

• Students and postdocs balancing interests in both science and entrepreneurship.
• Founders exploring Asian markets and making their innovations fundable.
• Executives in pharma and biotech seeking insights into partnerships in Asia.
• Researchers interested in collaboration opportunities in the region.
• Investors exploring the growth of life-science companies.

💼 Don’t miss the chance to connect with PwC as they are hiring! Join them for drinks and discussions.

Hosts:
PwC, Dr. Cecelia Brown-Fleming (Stanford), Kenneth Sng (Founder, Bedside), Dr. Jasmin Young (Co-founder, SingaporeConnect), Ken Mun Wong (Enterprise Singapore).

🍷 Enjoy delicious appetizers while networking and make sure to secure your spot as seats are limited!

👉 Register Here!